Cartilage intermediate layer protein 1 (CILP1): A novel mediator of cardiac extracellular matrix remodelling

[1]  N. Frangogiannis,et al.  The extracellular matrix in myocardial injury, repair, and remodeling , 2017, The Journal of clinical investigation.

[2]  N. Frangogiannis.  The role of transforming growth factor (TGF)-β in the infarcted myocardium. , 2017, Journal of thoracic disease.

[3]  R. Bonow,et al.  Therapeutic targets in heart failure: refocusing on the myocardial interstitium. , 2014, Journal of the American College of Cardiology.

[4]  B. Schroen,et al.  microRNA-122 down-regulation may play a role in severe myocardial fibrosis in human aortic stenosis through TGF-β1 up-regulation. , 2014, Clinical science.

[5]  Stephane Heymans,et al.  Myocardial Extracellular Matrix: An Ever-Changing and Diverse Entity , 2014, Circulation research.

[6]  C. Schalkwijk,et al.  Hypertension Is a Conditional Factor for the Development of Cardiac Hypertrophy in Type 2 Diabetic Mice , 2014, PloS one.

[7]  N. Turner,et al.  Combined effects of interleukin-1α and transforming growth factor-β1 on modulation of human cardiac fibroblast function. , 2013, Matrix biology : journal of the International Society for Matrix Biology.

[8]  Anushya Muruganujan,et al.  Large-scale gene function analysis with the PANTHER classification system , 2013, Nature Protocols.

[9]  F. Prinzen,et al.  Stretch-Induced Upregulation of Connective Tissue Growth Factor in Rabbit Cardiomyocytes , 2013, Journal of Cardiovascular Translational Research.

[10]  A. Didangelos,et al.  Proteomics Analysis of Cardiac Extracellular Matrix Remodeling in a Porcine Model of Ischemia/Reperfusion Injury , 2012, Circulation.

[11]  C. Little,et al.  Cartilage Intermediate Layer Protein 2 (CILP-2) Is Expressed in Articular and Meniscal Cartilage and Down-regulated in Experimental Osteoarthritis* , 2011, The Journal of Biological Chemistry.

[12]  G. Condorelli,et al.  MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling , 2010, Nature Cell Biology.

[13]  R. Goldschmeding,et al.  Connective tissue growth factor and cardiac fibrosis , 2009, Acta physiologica.

[14]  Leonid Kalichman.  The Genetics of Intervertebral Disc Degeneration , 2009 .

[15]  D. Hunter,et al.  The genetics of intervertebral disc degeneration. Associated genes. , 2008, Joint, bone, spine : revue du rhumatisme.

[16]  T. Ayoubi,et al.  Transcriptomic analysis of PPARalpha-dependent alterations during cardiac hypertrophy. , 2008, Physiological genomics.

[17]  B. Janssen,et al.  Specific and sustained down-regulation of genes involved in fatty acid metabolism is not a hallmark of progression to cardiac failure in mice. , 2006, Journal of molecular and cellular cardiology.

[18]  T. Kubo,et al.  Transcriptional regulation of the cartilage intermediate layer protein (CILP) gene. , 2006, Biochemical and biophysical research communications.

[19]  P. Carmeliet,et al.  Increased Cardiac Expression of Tissue Inhibitor of Metalloproteinase-1 and Tissue Inhibitor of Metalloproteinase-2 Is Related to Cardiac Fibrosis and Dysfunction in the Chronic Pressure-Overloaded Human Heart , 2005, Circulation.

[20]  Yusuke Nakamura,et al.  A functional SNP in CILP, encoding cartilage intermediate layer protein, is associated with susceptibility to lumbar disc disease , 2005, Nature Genetics.

[21]  D. Heinegård,et al.  Altered patterns and synthesis of extracellular matrix macromolecules in early osteoarthritis. , 2004, Matrix biology : journal of the International Society for Matrix Biology.

[22]  R. Terkeltaub,et al.  One of two chondrocyte-expressed isoforms of cartilage intermediate-layer protein functions as an insulin-like growth factor 1 antagonist. , 2003, Arthritis and rheumatism.

[23]  S. Ball,et al.  Chronic beta2-adrenergic receptor stimulation increases proliferation of human cardiac fibroblasts via an autocrine mechanism. , 2003, Cardiovascular research.

[24]  T. Rabelink,et al.  In vitro evidence for differential involvement of CTGF, TGFbeta, and PDGF-BB in mesangial response to injury. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[25]  L. Ryan,et al.  Expression of cartilage intermediate layer protein/nucleotide pyrophosphohydrolase parallels the production of extracellular inorganic pyrophosphate in response to growth factors and with aging. , 2000, Arthritis and rheumatism.

[26]  D. Heinegård,et al.  The human CILP gene: exon/intron organization and chromosomal mapping. , 1999, Matrix biology : journal of the International Society for Matrix Biology.

[27]  Yusuke Nakamura,et al.  Genomic organization, mapping, and polymorphisms of the gene encoding human cartilage intermediate layer protein (CILP) , 1999, Journal of Human Genetics.

[28]  D. Heinegård,et al.  Cloning and Deduced Amino Acid Sequence of a Novel Cartilage Protein (CILP) Identifies a Proform Including a Nucleotide Pyrophosphohydrolase* , 1998, The Journal of Biological Chemistry.

[29]  D. Heinegård,et al.  A Novel Cartilage Protein (CILP) Present in the Mid-zone of Human Articular Cartilage Increases with Age* , 1998, The Journal of Biological Chemistry.

[30]  Denis Vivien,et al.  Direct binding of Smad3 and Smad4 to critical TGFβ‐inducible elements in the promoter of human plasminogen activator inhibitor‐type 1 gene , 1998, The EMBO journal.

[31]  J. D. de Vries,et al.  Saturated but not mono-unsaturated fatty acids induce apoptotic cell death in neonatal rat ventricular myocytes. , 1997, Journal of lipid research.